Key result
The HI-PLUS trial is an ongoing cluster-randomized study designed to evaluate whether a structured case management program with telemonitoring improves quality of life in 1350 patients with heart failure.
Why the study?
Heart failure remains a leading cause of hospitalization and death that impairs quality of life despite advances in therapy, prompting investigation into whether structured multidisciplinary care can improve outcomes.
Does structured case management with telemonitoring improve quality of life in heart failure patients?
RCT (n=1,350)
Cluster-randomized, stratified block randomization
Yes
Does structured case management with telemonitoring improve quality of life in heart failure patients?
Answers are grounded in this paper and cite their sources.
The HI-PLUS trial will evaluate whether a complex intervention involving structured case management and telemonitoring can improve quality of life in heart failure patients in Germany.
INTRODUCTION: Heart failure (HF) remains a leading cause of hospitalization and death in Germany, significantly impairing patients' quality of life (QoL) despite advances in therapy. Structured, multidisciplinary care programs may improve long-term outcomes. HI-PLUS is a pragmatic trial investigating whether a complex intervention can improve QoL in HF patients. We describe the trial design and pilot feasibility study findings. METHODS AND RESULTS: HI-PLUS is a cluster-randomized, parallel-arm controlled trial (DRKS00031997) targeting 56 clusters, each comprising a cardiology practice and up to five general practitioners (GPs), targeting 1350 patients. The control arm receives guideline-recommended care. The intervention adds five elements: (a) care supported by specially trained non-physician staff HF qualified (HF-MPA); (b) accredited HF-MPA training curriculum certified by the German Society of Cardiology; (c) eHealth platform for telemonitoring and symptom reporting; (d) portable telemedical devices, if needed; and (e) enhanced communication between cardiologists and GPs facilitated by HF-MPAs and the eHealth platform. The primary endpoint is change in HF-specific QoL after 12 months, measured by the Kansas City Cardiomyopathy Questionnaire Overall Summary Score (KCCQ-OSS). A pilot feasibility study that was conducted prior to commencement of patient recruitment confirmed the feasibility and acceptability of the proposed trial procedures. CONCLUSION: The HI-PLUS trial addresses recognized gaps in HF care. If effective, it could serve as a scalable model for integrated HF care throughout Germany.
No takes yet. Share an insight, caveat, or question.
Schutzmeier et al. (2026) conducted an RCT in Heart failure with reduced left ventricular ejection fraction (LVEF ≤ 40%) (n=1,350). Structured case management with telemonitoring (HI-PLUS intervention) vs. Usual care (guideline-recommended care) was evaluated on Change in heart failure-specific quality of life from baseline to 12 months, measured by the Kansas City Cardiomyopathy Questionnaire Overall Summary Score (KCCQ-OSS). The HI-PLUS trial is an ongoing cluster-randomized study designed to evaluate whether a structured case management program with telemonitoring improves quality of life in 1350 patients with heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: